News
Gilead's CEO says he's committed to making sure people around the world can get his firm's new HIV prevention shot Yeztugo.
Emotionally intelligent AI can generate trust, motivate action, elevate the relationship between patients and their care ...
New brain-computer interface reduced time lag in translating thoughts into speech in a meaningful advance for the field.
Two advocates demand systemic change in addiction treatment that prioritizes safety and accountability above all else.
A U.K. health agency said the Alzheimer's drugs Kisunla and Leqembi are not cost-effective, meaning they won't be offered through the NHS.
Nicole Verdun, director of the office that reviews cell and gene therapies at the Food and Drug Administration, and her ...
The latest from the BIO 2025 conference: more universities open to private equity deals, emerging companies turn to new ...
A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...
This is the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to AI in health care and medicine.
Gilead has won FDA approval for an HIV prevention shot that is administered only once every six months. When will low-income ...
Duchenne muscular dystrophy families are sharing stories about Elevidys complications on social media. But they aren’t ...
Tennessee’s ban on gender-affirming care for minors can stand after the Supreme Court ruled that it does not constitute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results